Researchers are working on multiple innovative approaches to cancer vaccines, including nanoparticle delivery, a universal booster, and more.
Every month, the editors from the eight AACR journals select one “must read” article from each issue, which we...
On Saturday, May 4, Philadelphians flooded the Benjamin Franklin Parkway for the Franklin Institute’s ninth annual Philadelphia Science Festival....
Since the 1990s, the cancer mortality rate in the U.S. has steadily declined. Yet liver cancer death rates in...
During late March and early April, the U.S. Food and Drug Administration (FDA) made several decisions that have increased...
The Fifth AACR New Horizons in Cancer Research (NHiCR) international conference has concluded, and the more than 400 attendees...
Shenzhen is a remarkable place. It serves as a gateway to Hong Kong, and in its short 40-year history...
Greetings from Shenzhen, China, where the Fifth AACR New Horizons in Cancer Research (NHiCR) Conference is now underway. The event’s...
As a regular feature on this blog, we spotlight 10 “must read” articles selected by our editors from each...
The American Association for Cancer Research (AACR) Annual Meeting 2019 drew more than 21,000 attendees, providing a robust forum...
Therapeutics that target two proteins called cyclin-dependent kinase 4 (CDK4) and CDK6 have revolutionized treatment for breast cancer, Richard...